Active Shortage

GLYCOPYRROLATE INJECTION

OMEGA LABORATORIES LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of GLYCOPYRROLATE INJECTION in Canada?

Yes. GLYCOPYRROLATE INJECTION 0.2MG has an active shortage reported to Health Canada (last updated November 11, 2026).

Why is GLYCOPYRROLATE INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will GLYCOPYRROLATE INJECTION be available again?

The manufacturer's estimated resolution date is January 13, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusActive Shortage

Same-ingredient products on file4 products · 0 same form & route

Expected resolution~2 months remaining (estimate)

Affected strength0.2MG

Report last updated2026-11-11

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

GLYCOPYRROLATE INJECTION USP

SANDOZ CANADA INCORPORATED

0.2MG · DIN 02039508

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

GLYCOPYRROLATE INJECTION MULTIDOSE

OMEGA LABORATORIES LIMITED

0.2MG · DIN 02382849

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

SEEBRI BREEZHALER

NOVARTIS PHARMACEUTICALS CANADA INC

50MCG · DIN 02394936

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

CUVPOSA

MEDEXUS PHARMACEUTICALS INC.

1MG · DIN 02469332

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2027-01-13

~2 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02382857

Strength

0.2MG

Dosage Form

LIQUID

Route

INTRAVENOUS INTRAMUSCULAR

Active Ingredient

GLYCOPYRROLATE

Tier

Unrated

Last Updated

2026-11-11

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

GLYCOPYRROLATE INJECTION has 2 shortage/discontinuation reports on file — this is one of them.

2026-10-27

Resolved

Disruption of the manufacture of the drug.

Other Products from OMEGA LABORATORIES LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION USP

9MG · DIN 02150204

AMIKACIN SULFATE INJECTION

250MG · DIN 02486717

AMINOPHYLLINE INJ 25MG/ML

25MG · DIN 00582662

AMINOPHYLLINE INJ 50MG/ML

50MG · DIN 00582654

BAXEDIN 2% - 70%

DIN 02251477

BAXEDIN LIQ 20%

20% · DIN 00658413